Placing the UTI question in the context of what tirzepatide actually does and does not cause helps build an accurate picture of the medication risk profile
Stage I: Triage GLP-1 hair loss is a history, not a diagnosis A temporal relationship between GLP-1 treatment and shedding does not prove that the drug directly injured the follicle
PlexusDx recommends baseline mineral assessment before starting therapy to ensure you're not beginning treatment from a deficit
5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss, and gastroesophageal reflux disease